Cargando…

The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program

The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Pin-Nan, Chiu, Yen-Cheng, Chiu, Hung-Chih, Chien, Shih-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998410/
https://www.ncbi.nlm.nih.gov/pubmed/27015215
http://dx.doi.org/10.1097/MD.0000000000003193
_version_ 1782449936387801088
author Cheng, Pin-Nan
Chiu, Yen-Cheng
Chiu, Hung-Chih
Chien, Shih-Chieh
author_facet Cheng, Pin-Nan
Chiu, Yen-Cheng
Chiu, Hung-Chih
Chien, Shih-Chieh
author_sort Cheng, Pin-Nan
collection PubMed
description The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepatitis screening program in 2 remote villages of Southern Taiwan. All residents participated voluntarily and received questionnaire evaluation, blood tests, abdominal sonography, and LSM by TE. Residents with any one of following criteria including hepatitis B virus infection, hepatitis C virus infection, more than moderate alcohol drinking, and failure to obtain valid or reliable LSM were excluded. There were 831 residents participated in program. The valid and reliable LSM were obtained in 98.3% and 96.3% of residents, respectively. Finally, a total of 559 residents including 283 residents with nonalcoholic steatotic fatty liver disease (NAFLD) were enrolled for analysis. The mean liver stiffness was 4.9 ± 1.9 kPa. The liver stiffness increased in residents with diabetes mellitus (DM), higher body mass index (BMI), hypertension, abnormal waist–hip circumference ration (WHR), higher waist circumference (WC), and presence of fatty liver. Higher body weight, higher BMI, higher WC, abnormal WHR, abnormal aspartate aminotransferase (AST), abnormal alanine aminotransferase (ALT), and DM were the factors associated with significant fibrosis (liver stiffness ≥7 kPa) in either all participants or NAFLD residents. As determined by multivariate analysis, abnormal AST values and DM were the 2 independent factors in all participants (abnormal AST: OR 3.648, 95% CI 1.134–11.740, P = 0.03; DM: OR 2.882, 95% CI 1.282–6.478, P = 0.01) and in residents with NAFLD (abnormal AST: OR 4.197, 95% CI 1.154–15.262, P = 0.03; DM: OR 3.254, 95% CI 1.258–8.413, P = 0.02). LSM by TE is a useful screening tool in community. In residents, who were absence of chronic hepatitis virus infection or consumed less than moderate alcohol drinking, exhibited DM or abnormal AST values may consider a substantial group with significant fibrosis in community.
format Online
Article
Text
id pubmed-4998410
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49984102016-09-02 The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program Cheng, Pin-Nan Chiu, Yen-Cheng Chiu, Hung-Chih Chien, Shih-Chieh Medicine (Baltimore) 4500 The application of liver stiffness measurement (LSM) by transient elastography (TE) in general population remains to clarify. This cohort study aimed to examine the usefulness of TE and to identify factors associated with significant liver fibrosis in community-based population. We conducted a hepatitis screening program in 2 remote villages of Southern Taiwan. All residents participated voluntarily and received questionnaire evaluation, blood tests, abdominal sonography, and LSM by TE. Residents with any one of following criteria including hepatitis B virus infection, hepatitis C virus infection, more than moderate alcohol drinking, and failure to obtain valid or reliable LSM were excluded. There were 831 residents participated in program. The valid and reliable LSM were obtained in 98.3% and 96.3% of residents, respectively. Finally, a total of 559 residents including 283 residents with nonalcoholic steatotic fatty liver disease (NAFLD) were enrolled for analysis. The mean liver stiffness was 4.9 ± 1.9 kPa. The liver stiffness increased in residents with diabetes mellitus (DM), higher body mass index (BMI), hypertension, abnormal waist–hip circumference ration (WHR), higher waist circumference (WC), and presence of fatty liver. Higher body weight, higher BMI, higher WC, abnormal WHR, abnormal aspartate aminotransferase (AST), abnormal alanine aminotransferase (ALT), and DM were the factors associated with significant fibrosis (liver stiffness ≥7 kPa) in either all participants or NAFLD residents. As determined by multivariate analysis, abnormal AST values and DM were the 2 independent factors in all participants (abnormal AST: OR 3.648, 95% CI 1.134–11.740, P = 0.03; DM: OR 2.882, 95% CI 1.282–6.478, P = 0.01) and in residents with NAFLD (abnormal AST: OR 4.197, 95% CI 1.154–15.262, P = 0.03; DM: OR 3.254, 95% CI 1.258–8.413, P = 0.02). LSM by TE is a useful screening tool in community. In residents, who were absence of chronic hepatitis virus infection or consumed less than moderate alcohol drinking, exhibited DM or abnormal AST values may consider a substantial group with significant fibrosis in community. Wolters Kluwer Health 2016-03-25 /pmc/articles/PMC4998410/ /pubmed/27015215 http://dx.doi.org/10.1097/MD.0000000000003193 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 4500
Cheng, Pin-Nan
Chiu, Yen-Cheng
Chiu, Hung-Chih
Chien, Shih-Chieh
The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title_full The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title_fullStr The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title_full_unstemmed The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title_short The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program
title_sort application of liver stiffness measurement in residents without overt liver diseases through a community-based screening program
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998410/
https://www.ncbi.nlm.nih.gov/pubmed/27015215
http://dx.doi.org/10.1097/MD.0000000000003193
work_keys_str_mv AT chengpinnan theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chiuyencheng theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chiuhungchih theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chienshihchieh theapplicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chengpinnan applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chiuyencheng applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chiuhungchih applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram
AT chienshihchieh applicationofliverstiffnessmeasurementinresidentswithoutovertliverdiseasesthroughacommunitybasedscreeningprogram